IL-33/ST2 axis in autoimmune disease. 2022

Leila Shakerian, and Hanieh Kolahdooz, and Mitra Garousi, and Vahideh Keyvani, and Ramiar Kamal Kheder, and Tola Abdulsattar Faraj, and Esmaeil Yazdanpanah, and Seyed-Alireza Esmaeili
Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Interleukin-33 (IL-33) is a member of the IL-1 family and plays an ambivalent role in autoimmune diseases. IL-33 signals via the ST2 receptor and drives cytokine production in mast cells, basophils, eosinophils, NK cells, and T lymphocyte cells. The vital role of IL-33 as an active component gives rise to aberrant local and systemic damage which has been demonstrated in numerous inflammatory disorders and immune-mediated pathological conditions including multiple sclerosis (MS), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), psoriasis, Sjogren's syndrome, inflammatory bowel disease (IBD), etc. IL-33/ST2 axis can up-regulate pro-inflammatory cytokine release in autoimmune disease, however, in some metabolic diseases like diabetes mellitus type 1 IL-33 can be considered an anti-inflammatory cytokine. The purpose of this review is to discuss selected studies on IL-33/ST2 axis in autoimmune diseases and its potential role as a pathogenic or protective cytokine.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067596 Interleukin-33 A member of the INTERLEUKIN-1 protein family involved in the maturation of TH2 CELLS and the activation of MAST CELLS; BASOPHILS; EOSINOPHILS and NK CELLS. It is also produced by ENDOTHELIAL CELLS; EPITHELIAL CELLS and FIBROBLASTS; where it can function as an alarmin to modulate immune and inflammatory responses to tissue damage. IL-33,IL33,Interleukin 33
D000072179 Interleukin-1 Receptor-Like 1 Protein A receptor for INTERLEUKIN-33 that is related structurally to the interleukin-1 receptor. It contains three extracellular IMMUNOGLOBULIN-LIKE DOMAIN regions and associates with INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN upon binding IL-33 to initiate signaling. It may function in the response of HELPER T CELLS to INFLAMMATION. IL1RL1 Protein,Interleukin 1 Receptor-Related Protein,Interleukin-33 Receptor,Interleukin 1 Receptor Like 1 Protein,Interleukin 1 Receptor Related Protein,Interleukin 33 Receptor,Receptor, Interleukin-33
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D012859 Sjogren's Syndrome Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis. Sicca Syndrome,Sjogren Syndrome,Sjogrens Syndrome,Syndrome, Sicca,Syndrome, Sjogren's
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

Leila Shakerian, and Hanieh Kolahdooz, and Mitra Garousi, and Vahideh Keyvani, and Ramiar Kamal Kheder, and Tola Abdulsattar Faraj, and Esmaeil Yazdanpanah, and Seyed-Alireza Esmaeili
January 2018, Frontiers in immunology,
Leila Shakerian, and Hanieh Kolahdooz, and Mitra Garousi, and Vahideh Keyvani, and Ramiar Kamal Kheder, and Tola Abdulsattar Faraj, and Esmaeil Yazdanpanah, and Seyed-Alireza Esmaeili
December 2015, Cytokine & growth factor reviews,
Leila Shakerian, and Hanieh Kolahdooz, and Mitra Garousi, and Vahideh Keyvani, and Ramiar Kamal Kheder, and Tola Abdulsattar Faraj, and Esmaeil Yazdanpanah, and Seyed-Alireza Esmaeili
January 2017, Mediators of inflammation,
Leila Shakerian, and Hanieh Kolahdooz, and Mitra Garousi, and Vahideh Keyvani, and Ramiar Kamal Kheder, and Tola Abdulsattar Faraj, and Esmaeil Yazdanpanah, and Seyed-Alireza Esmaeili
April 2012, Immunologic research,
Leila Shakerian, and Hanieh Kolahdooz, and Mitra Garousi, and Vahideh Keyvani, and Ramiar Kamal Kheder, and Tola Abdulsattar Faraj, and Esmaeil Yazdanpanah, and Seyed-Alireza Esmaeili
March 2017, Cellular & molecular immunology,
Leila Shakerian, and Hanieh Kolahdooz, and Mitra Garousi, and Vahideh Keyvani, and Ramiar Kamal Kheder, and Tola Abdulsattar Faraj, and Esmaeil Yazdanpanah, and Seyed-Alireza Esmaeili
December 2019, Cytokine & growth factor reviews,
Leila Shakerian, and Hanieh Kolahdooz, and Mitra Garousi, and Vahideh Keyvani, and Ramiar Kamal Kheder, and Tola Abdulsattar Faraj, and Esmaeil Yazdanpanah, and Seyed-Alireza Esmaeili
January 2017, Military Medical Research,
Leila Shakerian, and Hanieh Kolahdooz, and Mitra Garousi, and Vahideh Keyvani, and Ramiar Kamal Kheder, and Tola Abdulsattar Faraj, and Esmaeil Yazdanpanah, and Seyed-Alireza Esmaeili
October 2019, International journal of molecular sciences,
Leila Shakerian, and Hanieh Kolahdooz, and Mitra Garousi, and Vahideh Keyvani, and Ramiar Kamal Kheder, and Tola Abdulsattar Faraj, and Esmaeil Yazdanpanah, and Seyed-Alireza Esmaeili
October 2013, Gut,
Leila Shakerian, and Hanieh Kolahdooz, and Mitra Garousi, and Vahideh Keyvani, and Ramiar Kamal Kheder, and Tola Abdulsattar Faraj, and Esmaeil Yazdanpanah, and Seyed-Alireza Esmaeili
September 2023, International immunopharmacology,
Copied contents to your clipboard!